Kapasa Medizintechnik GmbH (Kapasamed) is an innovative Medical Technology Company focusing on identifying and manufacturing medical devices that impact public health programs globally.
The company’s innovative product has been proven through successful clinical trials and carries the CE mark.
The device is intended to perform male circumcisions.Male circumcision has bee shown to reduce the incidence of HIV transmission.
The device and the method of safe circumcision that has been developed with it’s use, can replace more than 80% of the current surgical circumcision methods.
The Unicirc can substantially assist in reducing the backlog of circumcisions. UNAIDS have planned to circumcise at least 80% of 30 million males between the ages of 10 years and 49 years in Sub-Saharan Africa by 2021.
The Unicirc is used and distributed at this stage in South Africa.
A circumcision with the Unicirc can be completed at a single visit, no needles and no sutures are needed for the circumcision procedure.
For further information about the Unicirc, please follow the link: www.unicircglobal.com